BBT-401-1S (Bridge Biotherapeutics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBBT-401-1S (Bridge Biotherapeutics)
Drug Alias NamePellino-1 Inhibitor (Bridge Biotherapeutics)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionE3 ubiquitin-protein ligase pellino homolog 1 inhibitors
TargetsE3 ubiquitin-protein ligase pellino homolog 1
Therapy Area/IndicationsColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew ZealandMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesBridge Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBridge Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A